Optimising inflammatory bowel disease surveillance and dysplasia management—Where do we stand?
Open Access
- 8 November 2022
- journal article
- review article
- Published by Wiley in United European Gastroenterology Journal
- Vol. 10 (10) , 1054-1062
Abstract
Patients with longstanding extensive colitis are at an increased risk of developing colorectal cancer (CRC), and are therefore enrolled into colonoscopy screening programmes with the aim of detecting pre‐cancerous dysplastic change. However, current surveillance programs face multiple limitations relating to low levels of patient enrolment, missed lesions resulting in interval cancers, and uncertainties in the management of dysplasia. Patient counselling regarding the endoscopic and surgical management options of dysplastic lesions can prove particularly challenging, due to the variable risk of progression to cancer. In this review, we discuss the histopathological diagnosis of inflammatory bowel disease (IBD)‐associated dysplasia, describe the techniques to maximise dysplasia detection, and present a standardised multi‐disciplinary approach to managing patients with dysplasia. The challenges presented by this patient cohort highlight the clear clinical need for further research into the development and validation of non‐invasive markers of CRC risk in IBD patients undergoing surveillance.Keywords
This publication has 47 references indexed in Scilit:
- Histological evaluation in ulcerative colitisGastroenterology Report, 2014
- Cancer Risk After Resection of Polypoid Dysplasia in Patients With Longstanding Ulcerative Colitis: A Meta-analysisClinical Gastroenterology and Hepatology, 2014
- High Rates of Metachronous Colon Cancer or Dysplasia After Segmental Resection or Subtotal Colectomy in Crohnʼs ColitisInflammatory Bowel Diseases, 2013
- Declining Risk of Colorectal Cancer in Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Factors that Affect Adherence to Surveillance Colonoscopy in Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2013
- Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment optionsGut, 2011
- Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohortAlimentary Pharmacology & Therapeutics, 2011
- When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendationsInflammatory Bowel Diseases, 2010
- Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitisThe Journal of Pathology, 2001